Jerry L. Klein

Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.

D. Ettinger, E. Fishman, S. Order, 1991, International journal of radiation oncology, biology, physics.

Multimodality treatment of patients with advanced ovarian carcinoma.

D. Ettinger, S. Order, P. Leichner, 1982, International journal of radiation oncology, biology, physics.

Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01.

S. Leibel, C. Guse, S. Asbell, 1991, International journal of radiation oncology, biology, physics.

Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.

J. B. Garrison, D. Ettinger, R. E. Jenkins, 1981, International journal of radiation oncology, biology, physics.

Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.

B. Wessels, T. H. Nguyen, L. Dillehay, 1989, Cancer research.

Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody.

S. Order, P. Leichner, J. Klein, 1983, International journal of radiation oncology, biology, physics.

Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.

D. Ettinger, S. Siegelman, S. Order, 1983, Cancer treatment reports.